These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1971714)

  • 1. Effects of inhibition of norepinephrine synthesis on spontaneous and growth hormone-releasing hormone-induced GH secretion in cynomolgus macaques: evidence for increased hypothalamic somatostatin tone.
    Malozowski S; Hao EH; Ren SG; Genazzani AD; Kalogeras KT; Merriam GR
    Neuroendocrinology; 1990 Apr; 51(4):455-8. PubMed ID: 1971714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin.
    Lima L; Arce V; Tresguerres JA; Devesa J
    Neuroendocrinology; 1993 Jun; 57(6):1155-60. PubMed ID: 7901787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
    Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
    Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG; Macfarlane P; Levitt NS; Millar RP
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
    Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
    Malozowski S; Hao EH; Ren SG; Marin G; Liu L; Southers JL; Merriam GR
    J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
    Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
    J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inhibition of the hypothalamic somatostatinergic tone is not the cause of the enhanced growth hormone response to growth hormone-releasing hormone in patients with liver cirrhosis.
    Fanciulli G; Tomasi PA; Giusti M; Bertoncelli A; Deplano A; Garrucciu G; Delitala G
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):148-51. PubMed ID: 18095239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
    Eakman GD; Dallas JS; Ponder SW; Keenan BS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of amylin on growth hormone responsiveness to growth-hormone-releasing hormone in the rat.
    Netti C; Sibilia V; Pagani F; Lattuada N; Coluzzi M; Pecile A; Guidobono F
    Neuroendocrinology; 1995 Sep; 62(3):313-8. PubMed ID: 8538870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
    Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
    J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion.
    Carro E; Señarís RM; Seoane LM; Frohman LA; Arimura A; Casanueva FF; Diéguez C
    Neuroendocrinology; 1999 Jan; 69(1):3-10. PubMed ID: 9892845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of reversible growth retardation and growth hormone deficiency by blockade of norepinephrine synthesis in the rat.
    Malozowski S; Mamalaki E; Pleti M; Armando I; Goldstein D; Merriam GR
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):554-8. PubMed ID: 7906468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
    Wehrenberg WB; Wiviott SD; Voltz DM; Giustina A
    Endocrinology; 1992 Mar; 130(3):1445-50. PubMed ID: 1347008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
    Maiter D; Underwood LE; Martin JB; Koenig JI
    Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.